Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.5K
Overview
44.5K
Cancer Vaccines01:30

Cancer Vaccines

363
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
363

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hemorrhagic Fever Disease in STAT-1 Knockout Mice Infected with Lujo Virus.

Pathogens (Basel, Switzerland)·2026
Same author

V4020 Venezuelan Equine Encephalitis Vaccine: Mitigating Neuroinvasion and Reversion Through Rational Design.

Viruses·2025
Same author

Pathogenesis of Chapare virus in cynomolgus macaques.

EMI. Animal & environment·2025
Same author

Safety Toxicology Study of Reassortant Mopeia-Lassa Vaccine in Guinea Pigs.

Future pharmacology·2025
Same author

Natural History of Chapare Virus Infection in Strain 13 Guinea Pigs.

The Journal of infectious diseases·2025
Same author

Replication of the Venezuelan Equine Encephalitis Vaccine from a Synthetic PCR Fragment.

Pharmaceutics·2024

Related Experiment Video

Updated: Jun 29, 2025

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

12.6K

Single-Dose Immunogenic DNA Vaccines Coding for Live-Attenuated Alpha- and Flaviviruses.

Peter Pushko1, Igor S Lukashevich2, Dylan M Johnson3

  • 1Medigen, Inc., 8420 Gas House Pike Suite S, Frederick, MD 21701, USA.

Viruses
|March 28, 2024
PubMed
Summary

Single-dose immunogenic DNA (iDNA) vaccines utilize plasmid DNA to generate live-attenuated viruses, offering enhanced safety and immunogenicity. This novel platform provides a significant advantage for epidemic preparedness due to its single-dose efficacy.

Keywords:
DNA vaccinealphavirusattenuated virusflavivirusiDNAlive virus vaccine

More Related Videos

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
05:39

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

12.1K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.4K

Related Experiment Videos

Last Updated: Jun 29, 2025

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
10:39

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

Published on: June 25, 2015

12.6K
Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
05:39

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

12.1K
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.4K

Area of Science:

  • Virology
  • Vaccinology
  • Molecular Biology

Background:

  • Traditional vaccine development faces challenges in achieving rapid, broad-spectrum protection.
  • Nucleic acid vaccine platforms, including mRNA and DNA vaccines, have shown promise but often require multiple doses.
  • Live-attenuated vaccines offer high immunogenicity but can pose safety concerns.

Purpose of the Study:

  • To review the novel single-dose immunogenic DNA (iDNA) vaccine platform.
  • To highlight the mechanism and advantages of iDNA vaccines for viral diseases.
  • To assess the potential of iDNA vaccines for epidemic preparedness.

Main Methods:

  • Review of existing literature on iDNA vaccine technology.
  • Analysis of iDNA vaccine application in flavi- and alphavirus development.
  • Comparison of iDNA vaccines with other nucleic acid and live-attenuated vaccines.

Main Results:

  • iDNA vaccines use plasmid DNA to initiate replication of live-attenuated viruses in vitro or in vivo.
  • Single-dose iDNA vaccination elicits a robust immune response and protection against pathogenic viruses.
  • The iDNA platform combines advantages of reverse genetics, DNA immunization, and live-attenuated vaccine immunogenicity.

Conclusions:

  • iDNA vaccines represent a novel class of immunogenic DNA vaccines encoding entire live-attenuated viruses.
  • This platform offers enhanced safety and immunogenicity, surpassing single-dose efficacy compared to other nucleic acid vaccines.
  • iDNA vaccines hold significant potential for improved epidemic preparedness and vaccine development.